Sartorius Stedim Biotech SA
F:56S1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sartorius Stedim Biotech SA
F:56S1
|
FR |
|
A
|
AutoNation Inc
F:RWI
|
US |
|
Kubota Corp
F:KUO1
|
JP |
|
O
|
O'Reilly Automotive Inc
XMUN:OM6
|
US |
|
M
|
MAG Silver Corp
XMUN:MQ8
|
CA |
|
Takashimaya Co Ltd
OTC:TKSHF
|
JP |
|
Microport Scientific Corp
F:MSK
|
CN |
Wall St Price Targets
56S1 Price Targets Summary
Sartorius Stedim Biotech SA
According to Wall Street analysts, the average 1-year price target for 56S1 is 237.49 EUR with a low forecast of 213.28 EUR and a high forecast of 276.63 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 56S1's stock price target?
Price Target
237.49
EUR
According to Wall Street analysts, the average 1-year price target for 56S1 is 237.49 EUR with a low forecast of 213.28 EUR and a high forecast of 276.63 EUR.
What is the Revenue forecast for Sartorius Stedim Biotech SA?
Projected CAGR
12%
Over the last 13 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 8 years is 12%.
What is the Operating Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
17%
Over the last 13 years, the compound annual growth rate for Operating Income has been 15%. The projected CAGR for the next 8 years is 17%.
What is the Net Income forecast for Sartorius Stedim Biotech SA?
Projected CAGR
23%
Over the last 13 years, the compound annual growth rate for Net Income has been 13%. The projected CAGR for the next 8 years is 23%.
